Gastrointestinal Cancers and Personalized Medicine

• Eará dahkkit: Mini, Enrico (Doaimmaheaddji), Nobili, Stefania (Doaimmaheaddji)
• Materiálatiipa: Elektrovnnalaš Girjji oassi
• Giella: eaŋgalasgiella
• Almmustuhtton: Basel MDPI - Multidisciplinary Digital Publishing Institute 2022
• Fáttát: Medicine; Pharmacology; neutrophil-to-lymphocyte ratio; lymphocyte-to-monocyte ratio; prognosis; rectal cancer; mesorectum; sphincter preserving; molecular oncology; precision medicine; colorectal cancer; targeted therapy; molecular profiling; pancreatic cysts; thermal liquid biopsy; differential scanning calorimetry; diagnosis; generalized linear models; gene signature; mRNA expression; VANGL1; FFPE; neurotoxicity; oxaliplatin; chemotherapy-induced peripheral neuropathy; biomarker; genomics; neuropathy; FOLFOX; FOLFIRINOX; XELOX; gastrointestinal cancer; LAG-3; immune checkpoint; colon cancer; survival; microsatellite instability; immunotherapy; n/a
• Liŋkkat: DOAB: download the publication; DOAB: description of the publication

Gastrointestinal cancers, such as esophageal and gastric cancers, pancreatic cancers, hepatobiliary cancers, colorectal cancers and gastrointestinal stromal tumors, are frequently diagnosed at an advanced stage and have a dismal prognosis. Even in patients with potentially curative cancer, nearly 50...